Ms. Trudie Seeger, Ph.D., is the Global Head of Regulatory Affairs and Quality Assurance (QA) for Veeda Oncology and is responsible for overseeing all regulatory aspects of Veeda Oncology studies as well as ensuring quality, both within the company and in the conduct of the clinical trials.

With more than 25 years of diversified drug development and management experience, Ms. Seeger has an expansive career portfolio focusing on all Regulatory and QA aspects of Phase I-IV investigational studies of both drug and devices, with a focus on oncology products. She managed the development of two ethical products from conception to market for a major pharmaceutical company as well as directed regulatory strategy of an innovative biotechnology product to marketing authorization in the US, Europe and Asia. She is intimately familiar with ICH, GCP, QSR and GMP regulations as they relate to manufacturing, design, execution, conduct, and reporting of studies in the US and internationally. She is able to develop all forms of clinical and regulatory documents related to product development and marketing approval including INDs, IDEs, 510(k)s, PMAs, PDPs, NDAs and BLAs.

Ms. Seeger worked for 18 years in the pharmaceutical and biotech industry of which 14 years were in clinical research including positions as Clinical Research Associate, Project Manager, Director and Vice President. More recently, Ms. Seeger has utilized her QA and Regulatory experience and expertise in the field of Oncology to provide services to pharmaceutical, biologics, and the device industry.

Ms. Seeger received her BA in Biology from D’Youville College, MS in Natural Science and her Ph.D. in Experimental Pathology from State University of New York at Buffalo.